Nebenwirkungen · Mirvaso
Mirvaso 3 mg/g gel · Abschnitt 4.8 · PDF-Seite 5
HOS-127973 · Präparat HOS-096493
System Organ Class Frequency Adverse reactions Cardiac disorders Rare Bradycardia* Nervous system disorders Uncommon Headache, paraesthesia Eye disorders Uncommon Eyelid oedema Vascular disorders Common Flushing, pallor at the application site* Uncommon Dizziness* Rare Hypotension* Respiratory, thoracic and Uncommon Nasal congestion mediastinal disorders Gastrointestinal disorders Uncommon Dry mouth Skin and subcutaneous tissue Common Erythema, pruritus, rosacea, skin burning disorders sensation Uncommon Acne, allergic contact dermatitis, contact dermatitis, dermatitis, dry skin, pain of skin, skin discomfort, rash papular, skin irritation, skin warm, swelling face*, urticaria* Rare Angioedema* General disorders and Uncommon Feeling hot, peripheral coldness administration site conditions * Adverse reactions reported from post-marketing data.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-15T13:53:00Z · SHA-256 9c7e643a7b3870885a0241d066a8ccdd78ce3d5940f001edca4fc861c64df7e0 · Passage 63780df2efdc3897a3cc7b942f5e49e89c43e6676efc4286df61ce356310a0bf · Zeichen 942–2420 im Abschnitt